ArticleBritish journal of haematology2013

TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

Moshe E Gatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.